Rapamune 2 mg coated tablets
Sponsors
Oslo University Hospital HF, Centre Hospitalier Universitaire De Toulouse, Alexion Pharmaceuticals Inc.
Conditions
BAG3 Mutation Associated Dilated CardiomyopathyFamilial adenomatous polyposisVascular malfomation
Phase 1
Phase 2
Safety study for the use of Rapamycin in children with familial adenomatous polyposis - RAPA-4-FAP
Not yet recruitingCTIS2024-512079-11-00
Target: 25Updated: 2025-04-10
A single arm single center exploratory observational phase II study, aimed to detect long term changes in volume of port-wine macrocheilia and color of port-wine stain in patients undergoing surgery and laser therapy during sirolimus treatment. Quality of life and efficacy and safety of sirolimus will be assessed.
Not yet recruitingCTIS2024-511937-37-01
Target: 20Updated: 2026-06-15